Infectious Diseases Practice Questions

Q: Which of the following is the scientific name for the 'tiger mosquito'?

Aedes. **Explanation:** The correct answer is **Aedes** (specifically *Aedes albopictus*). **1. Why Aedes is correct:** *Aedes albopictus* is popularly known as the **'Asian Tiger Mosquito'** because of its distinctive black and white striped patterns on its body and legs, resembling a tiger. While *Aedes aegypti* is the primary vector for many diseases, *Aedes albopictus* is a highly invasive secondary vector. Both species are "day-biters" and breed in artificial containers (peridomestic breeders). **2. Why other options are incorrect:** * **Anopheles:** Known as the vector for **Malaria**. They typically rest at an angle to the surface and are nocturnal feeders. * **Culex:** Known as the **'House Mosquito'**. It is the primary vector for **Bancroftian Filariasis** and **Japanese Encephalitis**. They are "dirty water" breeders. * **Sand fly (*Phlebotomus*):** This is a small, fuzzy insect (not a mosquito) responsible for transmitting **Kala-azar** (Visceral Leishmaniasis). **3. High-Yield Clinical Pearls for NEET-PG:** * **Diseases transmitted by Aedes:** Dengue (Breakbone fever), Chikungunya, Zika virus, Yellow Fever, and Rift Valley Fever. * **Biting Habit:** They are **"Day biters"** (peak activity in early morning and late afternoon). * **Breeding:** They are **"Container breeders"** (flower pots, discarded tires, overhead tanks). * **Flight Range:** Short flight range, usually less than 100 meters. * **Control:** The most effective control measure is "Environmental Modification" (source reduction) and the use of larvicides like Abate (Temephos).

Q: Which of the following groups is typically NOT a target for specific HIV intervention programs?

Doctors and nursing professionals. **Explanation:** The core concept in HIV epidemiology is the identification of **High-Risk Groups (HRGs)** and **Bridge Populations**. Targeted Interventions (TIs) under the National AIDS Control Programme (NACP) are designed for groups with high behavioral risk or those who act as a "bridge" for transmission from high-risk individuals to the general population. **1. Why Option D is Correct:** **Doctors and nursing professionals** are not considered a "target group" for specific HIV behavioral intervention programs. While they face **occupational risk** (accidental needle-stick injuries), they are not a high-risk group in terms of behavioral transmission (unprotected sex or IV drug use). Their protection is managed through **Universal Work Precautions** and **Post-Exposure Prophylaxis (PEP)** protocols, rather than community-based behavioral interventions. **2. Why the other options are Incorrect:** * **Migrant labourers (A) and Long-distance truckers (C):** These are classified as **Bridge Populations**. Due to long periods away from home, they are more likely to visit female sex workers (FSWs) and subsequently transmit the virus to their spouses (low-risk general population). * **Street children (B):** They are considered a **vulnerable group** due to high rates of substance abuse (including IDU) and potential for sexual exploitation. **High-Yield Clinical Pearls for NEET-PG:** * **Core Groups (High Risk):** Female Sex Workers (FSW), Men who have Sex with Men (MSM), Injecting Drug Users (IDU), and Transgenders (TG). * **Bridge Populations:** Truckers and Migrants. * **NACP Strategy:** Focuses on "Saturation of Coverage" for HRGs through Targeted Interventions. * **PEP for Healthcare Workers:** Should ideally be started within **2 hours** (maximum 72 hours) and continued for **28 days**.

Q: What does CBNAAT stand for?

Cartridge Based Nucleic Acid Amplification Test. **Explanation:** **CBNAAT** stands for **Cartridge Based Nucleic Acid Amplification Test**. It is a revolutionary molecular diagnostic tool used primarily for the rapid detection of *Mycobacterium tuberculosis* (MTB) and rifampicin resistance. **Why Option D is Correct:** The technology (commercially known as GeneXpert) utilizes a self-contained, single-use **cartridge** that houses all necessary reagents for DNA extraction, amplification, and detection. Because the entire process occurs within this closed cartridge, it minimizes the risk of cross-contamination and requires minimal laboratory infrastructure, making it a "point-of-care" test. **Why Other Options are Incorrect:** * **Options A, B, and C:** The terms "Category," "Case," and "Clinical" are incorrect prefixes. While CBNAAT is used for clinical diagnosis and case finding, the nomenclature specifically refers to the **method of delivery** (the cartridge system) rather than the clinical application. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** It is a hemi-nested real-time PCR assay that targets the **rpoB gene** of MTB. * **Turnaround Time:** Provides results within **2 hours**, significantly faster than traditional culture (which takes weeks). * **NTEP Guidelines:** Under the National Tuberculosis Elimination Programme (NTEP), CBNAAT is the **preferred first-line diagnostic test** for all presumptive TB cases, especially for pediatric TB, HIV-positive individuals, and extra-pulmonary TB. * **Sensitivity:** It has a much higher sensitivity than sputum smear microscopy, particularly in paucibacillary cases. * **Limitation:** It cannot differentiate between live and dead bacilli; hence, it is not used for monitoring treatment response.

Q: Screening for which of the following viral infections in blood donors is compulsory?

All of these. **Explanation:** In India, the **Drugs and Cosmetics Act (1940)** and its subsequent amendments mandate the screening of all donated blood units to ensure transfusion safety and prevent **Transfusion-Transmitted Infections (TTIs)**. **Why the correct answer is "All of these":** The mandatory screening protocol in India requires every unit of blood to be tested for **five specific pathogens** before it can be issued for clinical use. These include: 1. **HIV (Human Immunodeficiency Virus):** Types 1 and 2. 2. **HBV (Hepatitis B Virus):** Specifically testing for Hepatitis B Surface Antigen (HBsAg). 3. **HCV (Hepatitis C Virus):** Testing for anti-HCV antibodies. 4. **Syphilis:** Testing for *Treponema pallidum*. 5. **Malaria:** Testing for *Plasmodium* species. **Analysis of Options:** * **HIV, HBV, and HCV** are all highly infectious, blood-borne viruses that can lead to chronic, life-threatening conditions. Because they share common transmission routes and have significant "window periods," universal screening is the only way to safeguard the blood supply. Therefore, selecting only one (Options A, B, or C) would be incomplete. **High-Yield Clinical Pearls for NEET-PG:** * **Window Period:** This is the time between infection and the point when laboratory tests can detect the pathogen. **NAT (Nucleic Acid Testing)** is increasingly used in advanced centers to reduce this window period, though it is not yet universally mandatory in all government blood banks. * **Mandatory Tests:** Remember the "Big 5": HIV, HBV, HCV, Syphilis, and Malaria. * **Hepatitis B:** It is the most common TTI globally. * **Professional Donors:** Under Indian law, blood donation must be **voluntary and non-remunerated**; professional (paid) blood donation is strictly banned to reduce the risk of TTIs.

Q: Which of the following is NOT a characteristic of Aedes mosquitoes?

Their eggs can survive for more than a week without water.. ### Explanation The correct answer is **B**. While the option suggests a survival of "more than a week," the defining characteristic of *Aedes* eggs is their extreme resilience; they are **desiccation-resistant** and can survive in a dry state for **up to one year**. Stating they survive for just over a week significantly underestimates their biological hardiness, which is a key factor in their role as persistent urban vectors. **Analysis of Options:** * **Option A (Repeated biting):** This is a classic characteristic. *Aedes aegypti* is a nervous feeder; it is easily disturbed during a blood meal and will move to multiple hosts to complete its feeding, leading to rapid outbreaks. * **Option C (Vector for Dengue):** *Aedes aegypti* (primary) and *Aedes albopictus* (secondary) are the well-established vectors for Dengue, Chikungunya, Zika, and Yellow Fever. * **Option D (Extrinsic Incubation Period):** The extrinsic incubation period (the time taken for the virus to develop inside the mosquito before it becomes infective) is typically **8–10 days** (range 7-12 days) under standard tropical conditions. **High-Yield Clinical Pearls for NEET-PG:** * **Biting Habit:** They are **day-biters**, with peak activity at dawn and dusk. * **Breeding:** They prefer **artificial collections of clean water** (e.g., flower pots, discarded tires, desert coolers). * **Flight Range:** They have a short flight range, usually **less than 100 meters**, making them "house-dwelling" mosquitoes. * **Tiger Mosquito:** *Aedes albopictus* is known as the "Asian Tiger Mosquito" due to its striped body. * **Control:** The most effective control measure is "Source Reduction" (eliminating stagnant water).

Q: What is the incubation period for filariasis?

8 - 16 months. **Explanation:** In Lymphatic Filariasis, the **incubation period** refers to the time interval between the entry of infective larvae ($L_3$) via a mosquito bite and the first appearance of clinical signs and symptoms. For *Wuchereria bancrofti*, this period typically ranges from **8 to 16 months**, though it can vary based on the host's immune response and the intensity of infection. * **Why Option B is correct:** The biological development of the parasite from the $L_3$ stage to mature adults, followed by the host's inflammatory response to the adult worms, generally takes approximately 8 to 16 months to manifest clinically as lymphangitis or lymphadenitis. * **Why Options A, C, and D are incorrect:** 1–8 months (Option A) is too short for the parasite to mature and trigger a significant clinical immune response. Periods exceeding 16 months (Options C and D) represent outliers or delayed presentations rather than the standard epidemiological average defined in standard textbooks like Park’s PSM. **High-Yield Clinical Pearls for NEET-PG:** * **Pre-patent Period:** The time between the entry of infective larvae and the first appearance of microfilariae in the blood. For *W. bancrofti*, this is usually **6 to 12 months**. * **Vector:** *Culex quinquefasciatus* is the most common vector in India. * **Drug of Choice:** Diethylcarbamazine (DEC) 6 mg/kg for 12 days. * **Mass Drug Administration (MDA):** Uses a combination of DEC + Albendazole (or IDA: Ivermectin + DEC + Albendazole in specific areas) once a year to interrupt transmission.

Q: Which case finding tool for Tuberculosis has been stopped as a general measure?

Mass Miniature radiography. **Explanation:** **Mass Miniature Radiography (MMR)** was once a popular screening tool for Tuberculosis (TB) but has been discontinued as a general case-finding measure. The primary reasons for its withdrawal include its **low specificity** (leading to high false-positive rates), high operational costs, and the significant risk of **unnecessary radiation exposure** to the general population. Furthermore, MMR often failed to differentiate between active and inactive lesions, making it an inefficient tool for mass screening compared to modern diagnostic protocols. **Analysis of Incorrect Options:** * **Sputum Microscopy:** This remains the **backbone of TB diagnosis** in many high-burden settings (like India under NTEP) due to its high specificity for infectious cases and cost-effectiveness. * **Sputum Culture:** This is the **Gold Standard** for TB diagnosis. While it takes longer, it is essential for diagnosing paucibacillary TB and performing Drug Susceptibility Testing (DST). * **Tuberculin Testing (Mantoux):** This is used to detect **latent TB infection** or as a supportive diagnostic tool in pediatric TB. It is not a general case-finding tool for active TB but has not been "stopped"; it is used selectively. **High-Yield Clinical Pearls for NEET-PG:** * **Current Screening Strategy:** The National Tuberculosis Elimination Program (NTEP) now emphasizes **"Active Case Finding"** in high-risk groups rather than the general population. * **Diagnostic Choice:** **CBNAAT (GeneXpert)** is now the preferred initial diagnostic test for TB under NTEP, replacing sputum microscopy in many algorithms due to its ability to detect Rifampicin resistance simultaneously. * **Chest X-Ray:** While MMR is stopped, standard digital Chest X-rays are still used as a highly sensitive **screening tool** in symptomatic individuals before confirmatory testing.

Q: What is the recommended duration of treatment for MDR/XDR tuberculosis?

24 months. **Explanation:** The treatment of Drug-Resistant Tuberculosis (DR-TB) is significantly more complex and prolonged than drug-sensitive TB. According to the National Strategic Plan and WHO guidelines (NTEP), the standard duration for a **conventional MDR/XDR-TB regimen is 18 to 24 months**. In the context of NEET-PG, where a single duration is often sought, **24 months** is the established benchmark for the total duration (comprising 6–9 months of Intensive Phase and 18 months of Continuation Phase). **Why Option D is Correct:** MDR-TB (resistance to at least Isoniazid and Rifampicin) and XDR-TB (MDR plus resistance to a fluoroquinolone and at least one second-line injectable) require second-line drugs that are less potent and slower-acting. A duration of 24 months ensures complete sterilization of the slow-growing bacilli and prevents relapse. **Analysis of Incorrect Options:** * **Option A (6 months):** This is the standard duration for **Drug-Sensitive TB (DS-TB)** using the 2HREZ/4HR regimen. * **Option B (12 months):** While the newer "Shorter MDR-TB Regimen" (BPaL/BPaLM) can last 6–9 months, 12 months is not the standard for conventional MDR/XDR protocols. * **Option C (18 months):** This is the minimum duration for the Continuation Phase alone in conventional regimens; however, the *total* duration including the Intensive Phase extends to 24 months. **High-Yield Clinical Pearls for NEET-PG:** * **MDR-TB Definition:** Resistance to **H** (Isoniazid) and **R** (Rifampicin). * **Pre-XDR TB:** MDR-TB + resistance to any **Fluoroquinolone**. * **XDR-TB:** MDR-TB + resistance to any Fluoroquinolone + resistance to at least one **Group A drug** (Bedaquiline or Linezolid). * **BPaL Regimen:** A newer 6-month all-oral regimen (Bedaquiline, Pretomanid, Linezolid) is now being implemented for highly resistant cases, but 24 months remains the classic answer for conventional MDR/XDR-TB.

Q: For the field diagnosis of trachoma, the WHO recommends that follicular and intense trachoma inflammation should be assessed in which age group?

Children aged 0-10 years. ### Explanation **Correct Answer: C. Children aged 0-10 years** **1. Why it is correct:** Trachoma, caused by *Chlamydia trachomatis*, is the leading infectious cause of blindness worldwide. For epidemiological surveillance and field diagnosis, the WHO focuses on the **0–10 year age group** (specifically children aged 1–9 years) to assess the prevalence of active disease. This group represents the **reservoir of infection** where active inflammatory signs—**Trachomatous inflammation—Follicular (TF)** and **Trachomatous inflammation—Intense (TI)**—are most prevalent. Monitoring this cohort allows health authorities to determine if the community requires mass drug administration (MDA) with Azithromycin. **2. Why the other options are incorrect:** * **Option A & D:** While adult women and older populations are at the highest risk for **Trachomatous Trichiasis (TT)** and corneal scarring due to repeated childhood infections, they are not the primary group used for diagnosing the *active* transmission of the disease in a community. * **Option B:** The age range of 10–28 years is too broad and misses the peak window of active follicular infection, which typically declines after age 10 as immunity develops. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **WHO SAFE Strategy:** **S**urgery (for trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, and **E**nvironmental improvement. * **WHO Simplified Grading System (FISTO):** * **TF:** 5 or more follicles (>0.5mm) on the upper tarsal conjunctiva. * **TI:** Thickening obscuring >50% of deep tarsal vessels. * **TS:** Trachomatous Scarring. * **TT:** Trachomatous Trichiasis (at least one lash rubbing the eyeball). * **CO:** Corneal Opacity. * **Elimination Threshold:** Prevalence of TF in children aged 1–9 years must be **<5%** to indicate elimination as a public health problem.

Question 1

Which of the following is the scientific name for the 'tiger mosquito'?

Accepted Answer

Aedes

Answer

Anopheles

Answer

Culex

Answer

Sand fly

Question 2

Which of the following groups is typically NOT a target for specific HIV intervention programs?

Accepted Answer

Doctors and nursing professionals

Answer

Migrant labourers

Answer

Street children

Answer

Long distance truckers

Question 3

What does CBNAAT stand for?

Accepted Answer

Cartridge Based Nucleic Acid Amplification Test

Answer

Category Based Nucleic Acid Amplification Test

Answer

Case Based Nucleic Acid Amplification Test

Answer

Clinical Based Nucleic Acid Amplification Test

Question 4

Screening for which of the following viral infections in blood donors is compulsory?

Accepted Answer

All of these

Answer

HIV

Answer

HBV

Answer

HCV

Question 5

Which of the following is NOT a characteristic of Aedes mosquitoes?

Accepted Answer

Their eggs can survive for more than a week without water.

Answer

They exhibit repeated biting behavior.

Answer

They are vectors for dengue fever.

Answer

The extrinsic incubation period for parasite development and transmission is 7-8 days.

Question 6

What is the incubation period for filariasis?

Accepted Answer

8 - 16 months

Answer

1 - 8 months

Answer

16 - 24 months

Answer

More than 24 months

Question 7

Which case finding tool for Tuberculosis has been stopped as a general measure?

Accepted Answer

Mass Miniature radiography

Answer

Sputum microscopy

Answer

Sputum culture

Answer

Tuberculin Testing

Question 8

What is the recommended duration of treatment for MDR/XDR tuberculosis?

Accepted Answer

24 months

Answer

6 months

Answer

12 months

Answer

18 months

Question 9

For the field diagnosis of trachoma, the WHO recommends that follicular and intense trachoma inflammation should be assessed in which age group?

Accepted Answer

Children aged 0-10 years

Answer

Women aged 15-45 years

Answer

Population aged 10 to 28 years

Answer

Population above 25 years of age irrespective of sex

Question 10

Which of the following statements regarding the tuberculin test is true?

Accepted Answer

More than 10 mm of induration in 72 hours indicates a positive test.

Answer

It is used for the diagnosis of tuberculosis.

Answer

It measures the incidence of tuberculosis.

Answer

It measures immunity status against tuberculosis.

Infectious Diseases — MCQs

Infectious Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?